Gene · 2201
Papers2,084
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,084
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Aseptic loosening around total joint replacement in humans is regulated by miR-1246 and miR-6089 via the Wnt signalling pathway. | J Orthop Surg Res | 2024 | 38287447 | PubTator, text mining | PubMed |
| A Study of Polish Family with Scoliosis and Limb Contractures Expands the MYH3 Disease Spectrum. | Genes (Basel) | 2024 | 38275606 | PubTator, text mining | PubMed |
| The roles and regulatory mechanisms of TGF-β and BMP signaling in bone and cartilage development, homeostasis and disease. | Cell Res | 2024 | 38267638 | PubTator, text mining | PubMed |
| Prevalence of Genetic Variants and Deep Phenotyping in Patients with Thoracic Aortic Aneurysm and Dissection: A Cross-Sectional Single-Centre Cohort Study. | J Clin Med | 2024 | 38256594 | PubTator, text mining | PubMed |
| GSDMB: A novel, independent prognostic marker and potential new therapeutic target in clear cell renal cell carcinoma. | Oncol Lett | 2024 | 38249806 | PubTator, text mining | PubMed |
| Biomimetic Scaffolds Based on Mn2+-, Mg2+-, and Sr2+-Substituted Calcium Phosphates Derived from Natural Sources and Polycaprolactone. | Biomimetics (Basel) | 2024 | 38248604 | PubTator, text mining | PubMed |
| Methylglyoxal-Derived Nucleoside Adducts Drive Vascular Dysfunction in a RAGE-Dependent Manner. | Antioxidants (Basel) | 2024 | 38247509 | PubTator, text mining | PubMed |
| Identification of Six Pathogenic Genes for Tibetan Familial Ventricular Septal Defect by Whole Exome Sequencing. | J Surg Res | 2024 | 38215673 | PubTator, text mining | PubMed |
| Hereditary Thoracic Aortic Diseases. | Diagnostics (Basel) | 2024 | 38201421 | PubTator, text mining | PubMed |
| Genetic mutation and aqueous humor metabolites alterations in a family with Marfan syndrome. | Heliyon | 2024 | 38187261 | PubTator, text mining | PubMed |
| Conversion of the CG specific M.MpeI DNA methyltransferase into an enzyme predominantly methylating CCA and CCC sites. | Nucleic Acids Res | 2024 | 38164970 | PubTator, text mining | PubMed |
| De novo variants underlying monogenic syndromes with intellectual disability in a neurodevelopmental cohort from India. | Eur J Hum Genet | 2024 | 38114583 | PubTator, text mining | PubMed |
| Considerations for enhanced mesenchymal stromal/stem cell myogenic commitment in vitro. | Clin Transl Sci | 2024 | 38098144 | PubTator, text mining | PubMed |
| Quercetin antagonized advanced glycated end products induced apoptosis and functional inhibition of fibroblasts from the prolapsed uterosacral ligament. | Drug Discov Ther | 2024 | 38044121 | PubTator, text mining | PubMed |
| A Novel Splice Site Mutation in the FBN2 Gene in a Chinese Family with Congenital Contractural Arachnodactyly. | Biochem Genet | 2024 | 37962692 | PubTator, text mining | PubMed |
| Re-evaluation of a Fibrillin-1 Gene Variant of Uncertain Significance Using the ClinGen Guidelines. | Ann Lab Med | 2024 | 37840311 | PubTator, text mining | PubMed |
| A population-based survey of FBN1 variants in Iceland reveals underdiagnosis of Marfan syndrome. | Eur J Hum Genet | 2024 | 37684520 | PubTator, text mining | PubMed |
| A Phase II Trial of Nintedanib in Patients with Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma: In-Depth Analysis of Nintedanib Arm from the KCSG HN 15-16 TRIUMPH Trial. | Cancer Res Treat | 2024 | 37475136 | PubTator, text mining | PubMed |
| Mutation in mitral valve prolapse susceptible gene DCHS1 causes familial mitral annular disjunction. | J Med Genet | 2024 | 37399314 | PubTator, text mining | PubMed |
| Biology of Tenascin C and its Role in Physiology and Pathology. | Curr Med Chem | 2024 | 37021423 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2201/papers?page=5